Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Outcome Measure:

Percentage of patients treated by each treatment alternative.

Outcome Time Frame:

Between 2002 - 2008

Principal Investigator

Panagiotis Pontikis, MD

Investigator Role:

Study Director

Investigator Affiliation:

AstraZeneca Greece

Authority:

Greece: National Organization of Medicines

Study ID:

NIS-OGR-DUM-2007/1

NCT ID:

NCT00733213

Start Date:

January 2008

Completion Date:

March 2009

Related Keywords:

• Locally Advanced or Metastatic Prostate Cancer.
• Prostate Cancer, Treatment alternatives, Metastasis
• Prostatic Neoplasms